A number of possible mechanisms for a protective effect have been suggested, including reduced ACE2 expression in the airway (Jackson et al., 2020), eosinophilia (Ferastraoaru et al., 2021), or simply the existing use of beneficial corticosteroids in this population (Halpin et al., 2020). The gene discussed is ACE2; the disease is Increased total eosinophil count.